Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 41

References for PMC Articles for PubMed (Select 21048008)


Detection and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006.

Adam HJ, Louie L, Watt C, Gravel D, Bryce E, Loeb M, Matlow A, McGeer A, Mulvey MR, Simor AE; Canadian Nosocomial Infection Surveillance Program.

Antimicrob Agents Chemother. 2010 Feb;54(2):945-9. doi: 10.1128/AAC.01316-09. Epub 2009 Nov 30.


Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals.

Sader HS, Jones RN, Rossi KL, Rybak MJ.

J Antimicrob Chemother. 2009 Nov;64(5):1024-8. doi: 10.1093/jac/dkp319. Epub 2009 Sep 10.


Lack of heteroresistance among Staphylococcus aureus isolates with vancomycin MICs of 2 micrograms per milliliter by automated testing.

Satola SW, Caliendo AM, Farley MM, Patel JB, Burd EM.

J Clin Microbiol. 2009 Aug;47(8):2680-1. doi: 10.1128/JCM.01184-09. Epub 2009 Jun 24. No abstract available.


Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia.

Maor Y, Hagin M, Belausov N, Keller N, Ben-David D, Rahav G.

J Infect Dis. 2009 Mar 1;199(5):619-24. doi: 10.1086/596629.


Incidence and characteristics of vancomycin nonsusceptible strains of methicillin-resistant Staphylococcus aureus at Hershey Medical Center.

Kosowska-Shick K, Ednie LM, McGhee P, Smith K, Todd CD, Wehler A, Appelbaum PC.

Antimicrob Agents Chemother. 2008 Dec;52(12):4510-3. doi: 10.1128/AAC.01073-08. Epub 2008 Oct 6.


Characterization of vancomycin-heteroresistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007).

Rybak MJ, Leonard SN, Rossi KL, Cheung CM, Sader HS, Jones RN.

J Clin Microbiol. 2008 Sep;46(9):2950-4. doi: 10.1128/JCM.00582-08. Epub 2008 Jul 16. Erratum in: J Clin Microbiol. 2008 Dec;46(12):4119. Sadar, Helio S [corrected to Sader, Helio S].


Evaluation of a new Etest vancomycin-teicoplanin strip for detection of glycopeptide-intermediate Staphylococcus aureus (GISA), in particular, heterogeneous GISA.

Yusof A, Engelhardt A, Karlsson A, Bylund L, Vidh P, Mills K, Wootton M, Walsh TR.

J Clin Microbiol. 2008 Sep;46(9):3042-7. doi: 10.1128/JCM.00265-08. Epub 2008 Jul 2.


A multi-center blinded study on the efficiency of phenotypic screening methods to detect glycopeptide intermediately susceptible Staphylococcus aureus (GISA) and heterogeneous GISA (h-GISA).

Voss A, Mouton JW, van Elzakker EP, Hendrix RG, Goessens W, Kluytmans JA, Krabbe PF, de Neeling HJ, Sloos JH, Oztoprak N, Howe RA, Walsh TR.

Ann Clin Microbiol Antimicrob. 2007 Sep 24;6:9.


Prevalence and characteristics of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia in a tertiary care center.

Maor Y, Rahav G, Belausov N, Ben-David D, Smollan G, Keller N.

J Clin Microbiol. 2007 May;45(5):1511-4. Epub 2007 Mar 7.


Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period.

Wang G, Hindler JF, Ward KW, Bruckner DA.

J Clin Microbiol. 2006 Nov;44(11):3883-6. Epub 2006 Sep 6.


Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia.

Howden BP, Johnson PD, Ward PB, Stinear TP, Davies JK.

Antimicrob Agents Chemother. 2006 Sep;50(9):3039-47.


Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy.

Sakoulas G, Moellering RC Jr, Eliopoulos GM.

Clin Infect Dis. 2006 Jan 1;42 Suppl 1:S40-50. Review.


A 1 year surveillance study of glycopeptide-intermediate Staphylococcus aureus strains in a French hospital.

Garnier F, Chainier D, Walsh T, Karlsson A, Bolmström A, Grelaud C, Mounier M, Denis F, Ploy MC.

J Antimicrob Chemother. 2006 Jan;57(1):146-9. Epub 2005 Nov 14. Erratum in: J Antimicrob Chemother. 2006 Mar;57(3):583.


hGISA: seek and ye shall find.

Howe RA, Walsh TR.

Lancet. 2004 Aug 7-13;364(9433):500-1. No abstract available.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk